Skip to content

    ACCENDRA HEALTH INC/VA/ (ACH) stock price & financials

    View ACH earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance75.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $686.85M
    -$1.28B
    $673.88M
    $681.92M
    $697.26M
    +1.5%
    $708.97M
    $627.78M
    -6.8%
    $613.23M
    -10.1%
    Weakening
    Operating Profit
    $31.08M
    -$275.43M
    $19.79M
    -$39.71M
    $26.47M
    -14.8%
    $20.91M
    $17.13M
    -13.5%
    -$35.15M
    +11.5%
    Stable
    Net Profit
    -$12.77M
    -$296.12M
    -$24.98M
    -$869.06M
    -$150.28M
    -1076.8%
    -$56.33M
    +81.0%
    -$6.47M
    +74.1%
    -$89.07M
    +89.8%
    Strengthening
    EPS
    $-0.17
    $-0.32
    $-11.30
    $-1.94
    -1041.2%
    $-0.08
    +75.0%
    $-1.16
    +89.7%
    Strengthening
    Other Income
    -$1.17M
    -$1.45M
    -$975.0K
    -$942.0K
    -$1.08M
    +7.9%
    -$949.0K
    +34.6%
    -$1.02M
    -4.9%
    -$643.0K
    +31.7%
    Strengthening
    Interest
    $28.95M
    $17.37M
    $24.21M
    $26.01M
    $29.03M
    +0.3%
    $27.93M
    +60.8%
    $32.35M
    +33.6%
    $34.54M
    +32.8%
    Strengthening
    Depreciation
    Profit before Tax
    $958.0K
    -$294.25M
    -$5.40M
    -$84.95M
    -$3.63M
    -479.4%
    -$7.97M
    +97.3%
    -$16.25M
    -201.0%
    -$87.63M
    -3.2%
    Weakening
    MarginsOPM
    4.5%
    21.5%
    2.9%
    -5.8%
    3.8%
    -15.9%
    3.0%
    -86.3%
    2.7%
    -7.1%
    -5.7%
    +1.5%
    Weakening
    Tax
    -31.6%
    -9.9%
    29.4%
    1.3%
    -54.3%
    -71.5%
    -18.5%
    -86.6%
    60.2%
    +104.6%
    -1.6%
    -224.1%
    Weakening
    ReturnsROIC
    1.3%
    29.0%
    2.4%
    85.1%
    14.7%
    +1076.8%
    5.5%
    -81.0%
    0.6%
    -74.1%
    8.7%
    -89.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$66.31M$67.03M$83.06M$55.71M$69.47M$243.04M$27.57M$281.99M$7.65M
    Short-Term Investments
    Total Current Assets$2.54B$2.41B$2.14B$2.32B$2.30B$2.10B$2.02B$547.87M$271.45M
    Net PP&E$323.94M$457.65M$460.42M$511.24M$858.93M$840.50M$376.21M$365.26M$305.67M
    Goodwill$414.12M$393.18M$394.09M$390.19M$1.64B$1.64B$1.23B$1.23B$1.23B
    Intangibles$314.18M$285.02M$243.35M$209.75M$445.04M$361.83M$210.06M$136.47M$78.01M
    Total Assets$3.77B$3.64B$3.34B$3.54B$5.39B$5.09B$4.66B$2.45B$2.11B
    LiabilitiesTotal Current Liabilities$1.47B$1.42B$1.35B$1.34B$1.57B$1.89B$1.85B$947.08M$666.22M
    Short-Term Debt$28.69M$51.24M$39.95M$17.91M$206.90M$42.87M$250.00M$0
    Long-Term Debt$1.65B$1.51B$986.02M
    Long-Term Leases$0$117.08M$119.93M$162.24M$215.47M$222.43M$89.47M$70.32M$63.23M
    Total Liabilities$3.26B$3.18B$2.62B$2.60B$4.44B$4.17B$4.07B$2.91B$2.66B
    EquityCommon Stock & APIC$124.59M$125.69M$146.94M$150.87M$152.56M$153.09M$154.40M$152.78M$153.81M
    Retained Earnings$200.67M$137.77M$167.02M$387.62M$410.01M$368.71M$27.16M-$1.08B-$1.18B
    Total Equity$518.42M$462.15M$712.05M$938.50M$966.74M$945.30M$586.36M-$460.98M-$550.94M
    HighlightsNet Cash / (Debt)-$1.61B-$1.49B-$942.91M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$115.59M$166.09M$339.22M$124.18M$325.01M$740.71M$161.50M
    Cash from Investing-$815.83M-$51.90M$80.07M-$53.63M-$1.80B-$137.25M-$116.53M$144.42M$268.22M
    Cash from Financing$701.07M-$130.20M-$379.39M-$129.48M$1.50B-$417.33M-$267.60M$188.08M-$157.29M
    SummaryCapital Expenditure-$44.87M-$42.42M-$50.42M-$40.98M-$158.09M-$172.38M-$170.29M-$190.96M-$176.77M
    Free Cash Flow$70.72M$123.67M$288.80M$83.19M$166.92M$568.34M-$8.79M
    FCF Margin0.8%1.3%3.4%0.9%1.7%22.3%-0.3%

    Ratios